Spreadsheet: 2ae5d62b-4069-41f5-a6ac-424f9a7bf1fd
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
17PRN | Test | 17PRN | Pregnenolone and 17-Hydroxypregnenolone | Pregnenolone and 17-OH Pregnenolone | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | Plain, Red-Top Tube: Red |  |  | 1 | mL | Collection Container/Tube:  Preferred: Red top  Acceptable: Serum gel Submission Container/Tube: Plastic vial [NAME]: 1 mL | 0.5 mL | Hemolysis	Mild OK; Gross OK Thawing	Warm reject; Cold reject Lipemia	Mild OK; [NAME] OK Icterus	Mild OK; [NAME] OK Other	NA | PREGNENOLONE CHILDREN* Males 0-6 years: not established 7-9 years: <206 ng/dL 10-12 years: <152 ng/dL 13-15 years: 18-197 ng/dL 16-17 years: 17-228 ng/dL Tanner Stages Stage I: <157 ng/dL Stage II: <144 ng/dL Stage III: <215 ng/dL Stage IV-V: 19-201 ng/dL   Females 0-6 years: not established 7-9 years: <151 ng/dL 10-12 years: 19-220 ng/dL 13-15 years: 22-210 ng/dL 16-17 years: 22-229 ng/dL Tanner Stages Stage I: <172 ng/dL Stage II: 22-229 ng/dL Stage III: 34-215 ng/dL Stage IV-V: 26-235 ng/dL   ADULTS > or =18 years: 33-248 ng/dL *Kushnir MM, [NAME], [NAME], et al: Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Clin Chem 2006;52(8):1559-1567   17-HYDROXYPREGNENOLONE CHILDREN* Males Premature (26-28 weeks): 1,219-9,799 ng/dL Premature (29-36 weeks): 346-8,911 ng/dL Full term (1-5 months): 229-3,104 ng/dL 6 months-364 days: 221-1,981 ng/dL 1-2 years: 35-712 ng/dL 3-6 years: <277 ng/dL 7-9 years: <188 ng/dL 10-12 years: <393 ng/dL 13-15 years: 35-465 ng/dL 16-17 years: 32-478 ng/dL Tanner Stages Stage I: <209 ng/dL Stage II: <356 ng/dL Stage III: <451 ng/dL Stage IV-V: 35-478 ng/dL   Females Premature (26-28 weeks): 1,219-9,799 ng/dL Premature (29-36 weeks): 346-8,911 ng/dL Full term (1-5 months): 229-3,104 ng/dL 6 months-364 days: 221-1,981 ng/dL 1-2 years: 35-712 ng/dL 3-6 years: <277 ng/dL 7-9 years: <213 ng/dL 10-12 years: <399 ng/dL 13-15 years: <408 ng/dL 16-17 years: <424 ng/dL Tanner Stages Stage I: <236 ng/dL Stage II: <368 ng/dL Stage III: <431 ng/dL Stage IV-V: <413 ng/dL   ADULTS Males > or =18 years: 55-455 ng/dL Females > or =18 years: 31-455 ng/dL *Kushnir MM, [NAME], [NAME], et al: Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Clin Chem 2006;52(8):1559-1567 | Monday, Thursday; 8 a.m. | 2 days | 8 days |  | Profile |  |  |  |  | Rochester
17PRN | [NAME] | SERUM | Serum |  |  |  | Frozen | 14 days
17PRN | Component | PREGN | Pregnenolone, Serum | Pregnenolone, S | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) |  |  |  | 0.5 | mL | Collection Container/Tube:  Preferred: Red top  Acceptable: Serum gel Submission Container/Tube: Plastic vial [NAME]: 1 mL | 0.5 mL | Hemolysis	Mild OK; Gross OK Thawing	Warm reject; Cold reject Lipemia	Mild OK; [NAME] OK Icterus	Mild OK; [NAME] OK Other	NA | CHILDREN* Males 0-6 years: not established 7-9 years: <206 ng/dL 10-12 years: <152 ng/dL 13-15 years: 18-197 ng/dL 16-17 years: 17-228 ng/dL Tanner Stages Stage I: <157 ng/dL Stage II: <144 ng/dL Stage III: <215 ng/dL Stage IV-V: 19-201 ng/dL   Females 0-6 years: not established 7-9 years: <151 ng/dL 10-12 years: 19-220 ng/dL 13-15 years: 22-210 ng/dL 16-17 years: 22-229 ng/dL Tanner Stages Stage I: <172 ng/dL Stage II: 22-229 ng/dL Stage III: 34-215 ng/dL Stage IV-V: 26-235 ng/dL   ADULTS > or =18 years: 33-248 ng/dL *Kushnir MM, [NAME], [NAME], et al: Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Clin Chem 2006;52(8):1559-1567 | Monday, Tuesday, Thursday  8:00am. | 2 days | 6 days | 1 | 84140 |  |  | Yes | Yes
PREGN | [NAME] | SERUM | Serum |  |  |  | Frozen | 14 days
PREGN | Result | 88645 | Pregnenolone, S | Pregnenolone, S | Numeric |  |  |  |  | ng/dL |  |  |  |  |  |  |  |  |  | 2837-3
17PRN | Component | 17OHP | 17-Hydroxypregnenolone, Serum | 17-Hydroxypregnenolone, S | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | Plain, Red-Top Tube: Red |  |  | 0.5 | mL | Collection Container/Tube:  Preferred: Red top  Acceptable: Serum gel Submission Container/Tube: Plastic vial [NAME]: 1 mL | 0.5 mL | Hemolysis	Mild OK; Gross OK Thawing	Warm reject; Cold reject Lipemia	Mild OK; [NAME] OK Icterus	Mild OK; [NAME] OK Other	NA | CHILDREN* Males Premature (26-28 weeks): 1,219-9,799 ng/dL Premature (29-36 weeks): 346-8,911 ng/dL Full term (1-5 months): 229-3,104 ng/dL 6 months-364 days: 221-1,981 ng/dL 1-2 years: 35-712 ng/dL 3-6 years: <277 ng/dL 7-9 years: <188 ng/dL 10-12 years: <393 ng/dL 13-15 years: 35-465 ng/dL 16-17 years: 32-478 ng/dL   TANNER STAGES Stage I: <209 ng/dL Stage II: <356 ng/dL Stage III: <451 ng/dL Stage IV-V: 35-478 ng/dL Females Premature (26-28 weeks): 1,219-9,799 ng/dL Premature (29-36 weeks): 346-8,911 ng/dL Full term (1-5 months): 229-3,104 ng/dL 6 months-364 days: 221-1,981 ng/dL 1-2 years: 35-712 ng/dL 3-6 years: <277 ng/dL 7-9 years: <213 ng/dL 10-12 years: <399 ng/dL 13-15 years: <408 ng/dL 16-17 years: <424 ng/dL   TANNER STAGES Stage I: <236 ng/dL Stage II: <368 ng/dL Stage III: <431 ng/dL Stage IV-V: <413 ng/dL ADULTS Males > or =18 years: 55-455 ng/dL Females > or =18 years: 31-455 ng/dL *Kushnir MM, [NAME], [NAME], et al: Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Clin Chem 2006;52(8):1559-1567 | Monday, Tuesday, Thursday; 8 a.m. | 2 days | 6 days | 1 | 84143 |  |  | Yes | Yes
17OHP | [NAME] | SERUM | Serum |  |  |  | Frozen | 14 days
17OHP | Result | 81151 | 17-Hydroxypregnenolone, S | 17-Hydroxypregnenolone, S | Numeric |  |  |  |  | ng/dL |  |  |  |  |  |  |  |  |  | 6765-2